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Abstract
Background: Cell specific states of the chromatin are programmed during mammalian development. Dynamic DNA
methylation across the developing embryo guides a program of repression, switching off genes in most cell types. Thus, the
majority of the tissue specific differentially methylated sites (TS-DMS) must be un-methylated CpGs.
Methodology and Principal Findings: Comparison of expanded Methyl Sensitive Cut Counting data (eMSCC) among four
tissues (liver, testes, brain and kidney) from three C57BL/6J mice, identified 138,052 differentially methylated sites of which
23,270 contain CpGs un-methylated in only one tissue (TS-DMS). Most of these CpGs were located in intergenic regions,
outside of promoters, CpG islands or their shores, and up to 20% of them overlapped reported active enhancers. Indeed,
tissue-specific enhancers were up to 30 fold enriched in TS-DMS. Testis showed the highest number of TS-DMS, but
paradoxically their associated genes do not appear to be specific to the germ cell functions, but rather are involved in
organism development. In the other tissues the differentially methylated genes are associated with tissue-specific
physiological or anatomical functions. The identified sets of TS-DMS quantify epigenetic distances between tissues,
generated during development. We applied this concept to measure the extent of reprogramming in the liver of mice
exposed to in utero or early postnatal nutritional stress. Different protocols of food restriction reprogrammed the liver
methylome in different but reproducible ways.
Conclusion and Significance: Thus, each identified set of differentially methylated sites constituted an epigenetic signature
that traced the developmental programing or the early nutritional reprogramming of each exposed mouse. We propose
that our approach has the potential to outline a number of disease-associated epigenetic states. The composition of
differentially methylated CpGs may vary with each situation, behaving as a composite variable, which can be used as a pre-
symptomatic marker for disease.
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Introduction
Animals develop from repeated division of a single cell (a
fertilized egg) as a result of precise spatio-temporal regulation of
gene expression. Combinatorial use of cis and trans DNA
regulatory elements permit commitment of cells to different
lineages. Once a differentiation path is chosen the trajectory of
gene expression is maintained through many cell generations. The
acquisition of this ‘‘cellular memory’’ is key for the assembly of the
different organized tissues, and is maintained largely by epigenetic
marks such as 5-methyl cytosine methylation [1–3]. During
development the genome is faithfully replicated millions of times
but the epi-genome varies with each cell type. Moreover, in
contrast to the genome, the epigenome is dynamic and sensitive to
the environment. Exposure to stress during critical stages of
development could cause subtle changes in the epigenome
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physiology [1,2,4–6]. Thus, small deviations in tissue-specific
methylation patterns could contribute to the developmental origins
of many adult diseases [7,8].
To understand the role of DNA methylation in the cell-type-
specification of the chromatin or in the onset of pathophysiological
mechanism, it is necessary to contrast the distribution of methyl-
marks across various tissues and different conditions. The ultimate
Figure 1. Identification of tissue differential methylated sites (T-DMS) led to the identification of tissue differentially methylated
regions (T-DMR). Averaged digestion frequencies were profiled for each tissue and depicted with the UCSC genome browser. The long RNA-seq
track generated by the transcriptome group at Cold Spring Harbor Laboratories and the Center for Genomic Regulation in Barcelona display the
density of mapped reads. Individual tissues were harvested from 8-month C57BL/6J mice. The UW ENCODE group generated the DNaseI
hypersensitivity track, the signal represent the density of reads mapped within a 150 bp sliding window. Tissues were harvested from mice of the
same strain and age as described above. A) region containing the entire Repin1 gene. B), C) and D) regions spanning the last exon of the Zfp467,
Zfp777 and Zfp618 genes respectively. E) scatter plot comparing digestion frequencies of liver replicates (upper panel) or different tissues (lower
panel). Data was collected for the ‘‘chr6: 48,537,207–48,558,557’’ interval. The solid lines represent the result of a linear regression; the dashed lines
defined the 95% interval of prediction. Data outside this interval could represent tissue differentially methylated CpGs. F) bisulfite sequencing analysis
confirmed the discovered tissue-specific differentially methylated region. Regions selected for this analysis are shown as black bars in the panelsA ,B
and C.
doi:10.1371/journal.pone.0072670.g001
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methylation. Most of the research done to address this problem
has focused on the function of promoters and their CpG islands
(CGIs), shaping the perception that the CGIs are the hotspots for
epigenetic regulation of tissue specific transcriptional activity [9]
[10–14]. However, technological advances in methylome analysis
have increasingly shown Tissue Specific Differentially Methylated
Regions (TS-DMR) as hypo-methylated loci existing outside
promoters and CGIs, [15–18]. We recently showed that most of
the hypo-methylated loci existing in the liver of an adult mouse are
located in introns or intergenic regions and do not meet commonly
accepted definitions of CGIs [15]. Indeed these CpG-poor un-
methylated loci showed the highest concentrations in DNA
regulatory sequences, many of which were liver specific [15].
We hypothesized that the epigenetic regulation of transcriptional
networks that specify tissues occurs primarily in CpG located
outside promoters.
Comparing the distribution of methylation sites in mouse gDNA
derived from liver, kidney, brain and testis we found 138,052
independent differentially methylated sites (DMS). One sixth of
them consisted of CpGs whose methylation levels were particularly
high or low in only one tissue, hence named tissue specific
differentially methylated sites (TS-DMS). Most of these are un-
methylated CpGs associated with tissue-specific expressed genes.
Functional profiles obtained from these genes suggest that relevant
aspects of tissue physiology would be epigenetically demarcated
during development. The distribution of methylation among a
minimal set of 23,270 CpG showed commonalities between
biological replicates and differences between tissues, suggesting
that these TS-DMS constitute unique epigenetic footprints created
during development. We detected further reprogramming of
methylation patterns drove by in utero and/or immediate postnatal
food restriction. We suggest that our approach can outline a
number of disease-associated epigenetic states. The composition of
DMS would be different for each situation representing highly
specific DNA methylation biomarker panels. Discovery of novel
epigenetic makers is an area of increasing interest in biomedical
research, however most of the newly discovered candidates have
been found by focusing on a small number of well-defined loci,
usually promoters and CGIs [19]. As these loci can be identified
either as methylated or un-methylated, they offer a limited
sensitivity or specificity for diagnosis, [20,21]. On the other hand,
a composite variable, such as the composition of CpGs in a set of
differentially methylated sites, can represent a larger number of
different situations covering wider applications.
Materials and Methods
Samples
Four tissues: brain (B), kidney (K), liver (L) and testis (T) were
obtained from each of three adult male C57Bl/6J mice. Fetal livers
were also derived from the same mouse strain. In addition, 16 liver
samples were used from three-week-old male ICR mice (Harlan,
Indianapolis, IN, USA) that were subjected to a study of
nutritional influences on diabetes and obesity risk [22,23]. This
study was carried out in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. Animal protocols ‘‘Proposal #
2009-0017 LN, DNA methylation in obesity and diabetes’’, were
approved by The National Institute of Environmental Health
Sciences Animal Care and Use Committee.
Genome-wide DNA methylation profiling using eMSCC
CpG tag libraries for eMSCC were prepared as described [15],
including the addition of equimolar amounts of un-methylated
lambda phage DNA (Promega, Cat.# D1521). All libraries were
sequenced by Expression Analysis (Durham, NC, USA) using an
Illumina Genome Analyzer IIx. Reads (30 to 50 million per
library) were aligned to the mouse reference genome (mm9) using
MOM [24].
Figure 2. Co-occurrence of differential tissue gene expression and differential tissue methylation at 39 terminal exons of a set of
Zfp genes. A, paired comparisons of the digestion frequencies (somatic tissues vs. testis) tabulated in Table 1 under the column header:
‘‘methylation in 39 exon’’. B and C, distribution of linear fold change (somatic tissues vs. testis) values for gene expression and methylation
respectively. Box plots represent the data tabulated under FCh columns in Table 1. D, paired comparison of gene expression (somatic tissues vs.
testis), the somatic tissue with the highest raw signal was chosen for comparison in each pair.
doi:10.1371/journal.pone.0072670.g002
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PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e72670Table 1. A set of tissue differentially expressed Zfp genes with TS-DMS in their 39 terminal exon.
Methylation in 39 exon
1
Gene expression: RNA-
seq
2
Gene List 59 CGI?
3 39 exon CGI?DMR in 39 exon B K L T FCh
4 B K L T FCh
5
Zfp92 no yes chrX:70,667,009–70,668,669 1.8 1.8 2.4 15.8 7.8 25 1 1 5 5
Zfp787 yes yes chr7:6,083,186–6,085,905 6.7 8.3 4.0 30.8 4.9 343 814 550 181 4.5
Zfp775 no yes chr6:48,569,295–48,571,527 3.1 2.0 1.7 36.6 16.2 140 168 62 56 3
Zfp768 yes yes chr7:134,486,685–134,488,364 2.6 7.4 5.3 27.1 5.3 313 1425 462 782 1.8
Zfp689 yes yes chr7:134,587,450–134,589,790 6.3 9.6 4.4 31.1 4.6 148 138 43 412 22.8
Zfp647 yes yes chr15:76,741,187–76,743,420 1.0 0.8 1.5 23.9 21.7 80 34 15 9 8.9
Zfp64 yes yes chr2:168,751,178–168,753,416 7.5 2.3 1.3 21.9 5.9 289 249 159 46 6.3
Zfp629 no yes chr7:134,754,156–134,757,445 2.1 2.9 0.6 36.0 19.1 235 275 131 200 1.4
Zfp536 yes yes chr7:38,264,240–38,266,631 4.1 4.0 2.7 21.1 5.9 397 3 2 28 14.2
Zfp467 yes yes chr6:48,387,913–48,389,959 14.8 12.0 7.0 30.1 2.7 251 605 235 27 22.4
Zfp398 yes yes chr6:47,816,064–47,817,270 0.6 0.4 0.2 6.3 6.3 300 315 87 146 2.2
Zfp358 yes yes chr8:3,494,937–3,497,650 1.5 1.3 1.4 29.2 20.9 901 1187 329 47 25.3
Zfp324 yes yes chr7:13,555,845–13,557,613 3.0 4.1 2.6 36.6 11.4 97 212 108 14 15.1
Zfp282 yes yes chr6:47,853,767–47,857,203 8.9 8.0 4.3 19.1 2.7 279 159 49 28 10.0
Zfp275 yes yes chrX:70,599,182–70,599,994 1.0 0.3 0.3 7.2 7.2 125 105 52 58 2.2
Zfp213 yes yes chr17:23,694,614–23,695,442 3.1 4.3 2.3 12.7 3.9 123 256 124 62 4.1
Zfpm2 yes no chr15:40,933,302–40,935,151 1.1 1.0 1.5 23.5 19.6 108 12 4 39 2.8
Zfp94 yes no chr7:25,087,544–25,089,206 1.4 0.9 1.0 24.2 22.0 97 31 15 44 2.2
Zfp809 yes no chr9:22,043,700–22,045,660 0.2 0.3 0.2 19.8 19.8 239 180 158 52 4.6
Zfp804a yes no chr2:82,099,024–82,099,872 2.9 12.4 3.2 24.2 3.9 181 1 1 1 181
Zfp791 no no chr8:87,633,541–87,638,183 1.6 1.6 1.3 14.8 10.1 470 526 544 307 1.8
Zfp780b no no chr7:28,746,705–28,746,943 6.3 7.1 5.2 26.0 4.2 52 15 16 6 8.7
Zfp764 yes no chr7:134,548,323–134,549,900 2.7 2.8 1.4 23.4 10.2 104 154 46 6 25.7
Zfp691 no no chr4:118,842,688–118,844,133 2.9 4.3 2.3 20.1 6.4 120 379 230 479 21.3
Zfp69 yes no chr4:120,602,876–120,604,472 1.5 2.1 0.8 34.9 23.6 28 14 3 17 1.6
Zfp672 yes no chr11:58,129,068–58,131,818 7.9 6.1 2.9 35.7 6.3 545 1083 424 711 1.5
Zfp668 yes no chr7:135,009,556–135,012,952 1.9 1.8 0.9 16.2 10.6 188 74 55 42 4.5
Zfp619 yes no chr7:46,790,771–46,795,803 0.3 0.4 0.4 18.8 18.8 43 21 9 5 8.6
Zfp612 yes no chr8:112,612,925–112,614,371 0.3 0.3 0.3 19.0 19.0 350 31 19 56 6.3
Zfp608 yes no chr18:55,057,322–55,060,683 4.2 7.2 3.8 19.4 3.8 101 86 19 273 22.7
Zfp42 no no chr8:44,380,959–44,381,843 0.8 1.6 2.4 17.2 10.9 3 1 2 80 226.7
Zfp341 yes no chr2:154,471,197–154,472,435 4.8 5.1 2.0 30.9 7.8 131 53 41 19 6.9
Zfp27 no no chr7:30,679,004–30,681,841 0.1 0.1 0.0 11.0 11.0 198 46 36 32 6.2
Zfp248 yes no chr6:118,388,618–118,389,661 0.4 0.3 0.4 16.2 16.2 12 2 1 2 6
Zfp239 no no chr6:117,820,865–117,823,017 3.3 4.7 8.2 24.6 4.6 675 76 2 109 6.2
Zfp180 yes no chr7:24,889,403–24,892,210 1.8 2.0 2.1 19.0 9.7 448 203 88 84 5.3
Zfp112 no no chr7:24,902,263–24,904,868 4.6 3.2 2.7 18.7 5.3 36 6 2 4 9
Zfp365 yes no chr10:67,350,323–67,351,704 4.8 3.9 3.5 36.3 8.9 3983 8 1 3 1327.7
Zfp809 yes no chr9:22,043,950–22,044,900 0.2 0.3 0.2 19.8 19.8 239 180 158 52 4.6
1) The level of methylation in the 39exon of each Zfp gene was calculated for each tissue by adding the averaged digestion frequencies of triplicates at each CpG
identified in the exon, and dividing by the number of identified CpGs in the exon. A digestion frequency around 26 is typically found in un-methylated CGI (Figure S2E
in Supporting Information S1), where df,10 are associated to methylated CGI.
2) The numbers represent the raw signal for the density of mapped reads (wiggle format) in the CSHL Long RNA-seq track in the UCSC genome browser (NCBI37/mm9
assembly).
3) All 59 CGI were found un-methylated in all the tissues for each Zfp gene listed in this table.
4) Fold changes calculated as the ratio between df at testes and the avg df of the three somatic tissues.
5) Fold change is calculated as the ratio of somatic tissue vs testes. The somatic tissue with the highest RNA-seq signal or ‘‘df’’ was chose in each case. Abbreviation: CGI
for CpG Island, df for digestion frequency, B for brain, K for kidney, L for liver and T for testes.
doi:10.1371/journal.pone.0072670.t001
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This procedure has four main steps: 1) For each of 12 samples
(3 per tissue), we normalized the reads at each CpG by a factor
that is proportional to the total number of reads in the sample; 2)
We aligned all the reads in each sample to Takai-Jones CGIs (TJ-
CGIs) and generated the distribution of the average normalized
methyl-sensitive-counts (digestion frequencies) of TJ-CGIs. We
chose the value at the valley of the distribution as the cutoff to filter
out CpGs presumed heavily methylated in all four tissues; 3) For
each CpG that passed the filter in step 2, we performed all six
pairwise comparisons of the four tissues, i.e. B-K, B-L, B-T, K-L,
K-T, L-T; where B, K, T and L represent brain, kidney, testis and
liver respectively and B-K, B-L, etc., represent the pair wise
comparisons. For each CpG, the average and the standard
deviation of the reads were calculated using all samples. The
standardized residual for each sample was then calculated by
dividing the difference between the observed numbers of reads for
that sample and the corresponding average by the standard
deviation. We plotted the quantiles of the residuals against the
quantiles of standard normal distribution to see if it is reasonable
to assume that the data are approximately normally distributed; 4)
We applied the mdFDR method to identify DMSs based on the p
values of all six possible t-tests. The mdFDR procedure allowed us
to control the overall false discovery rate for all pairwise
comparisons as well as the directional errors when declaring more
or less methylated states [25]. In this manner, we identified the
preliminary DMS. We next removed the pairs of comparison with
average normalized read differences between two tissues that were
less than the cutoff value generated from step 2, to ensure that two
tissues had a different methylation state at that CpG. Last, for each
DMS we averaged reads of each tissue and identified the sites with
methylation levels significantly high or low in only one tissue.
These sites were called TS-DMS.
Identification of DMS associated with nutritional history
Previously, an experiment was reported in which pregnant mice
were subjected to undernutrition (U) during the last third of their
pregnancy and this feeding regimen was continued during
lactation generating the UU pups, alternative some mothers were
changed to a control diet (C) during lactation and generated the
UC pups. CC and CU protocols were also implemented to
generate the respective pups. All pups were euthanized and their
livers analyzed [23]. We used 16 liver samples derived from the
same experiment: CC (n=4), CU (n=5), UC (n=2) and UU
(n=5) to profile changes in methylation using the approach
described in previous section.
CpG distribution related to UCSC known genes
CpGs were classified according to their genomic location: 1)
TSS region (23K bt o+2 Kb of the TSS); 2) gene body region; 3)
39 end region encompassing 3 Kb of DNA sequences downstream
of each transcriptional end; and 4) intergenic region. Coordinates
for the beginning and end of these regions were taken from the
mm9 building downloaded from the UCSC Genome Bioinfor-
matics browser (http://hgdownload.cse.ucsc.edu/goldenPath/
mm9/database/knownGene.txt.gz). The equally unmethylated
CpGs (497,547) were defined as the CpGs with the average
normalized df above the cutoff value of unmethylation in all four
tissues and excluding any overlapping with DMSs.
CpG distribution related to CGIs
CpGs were mapped to three regions relative to CGIs and their
2-kb flanking regions (shores), including inside CGI, in CGI
Figure 3. Summary of the findings of differential methylation
observed for the comparison of tissue. Of the 138,052 sites with
differentially methylated marks, called DMS, only 24,803 were also TS-
DMS, defined here as CpGs uniquely methylated or un-methylated in
one but not in the other tissues. The remaining 113,249 sites are just
DMS, meaning that methylation at these CpGs varies at a detectable
level among compared tissues.
doi:10.1371/journal.pone.0072670.g003
Figure 4. Distribution of TS-DMS relative to promoters, CGI,
CGI shores, experimentally determined un-methylated regions
(UMR) or shores of UMRs. A) Distribution of equally and tissue
differentially un-methylated CpGs relative to UCSC genes. B) Distribu-
tion of differentially un-methylated CpGs relative to CGIs and their 2-kb
shores. TJ-CGIs (Takai and Jones CpG islands), GGF-CGIs (Gardiner-
Garden and Frommer’s CpG islands), Epi-CGIs (epigenetically predicted
CpG islands), CGI clusters (CpG clusters), HMM CGI (Hidden Markov
Model predicted CpG islands).
doi:10.1371/journal.pone.0072670.g004
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definitions were used for this analysis [26–30].
Measures of the association between TS-DMS and tissue-
specific expressed genes
We used the Gene Expression Barcode 2.0 browser to obtain a
list of genes expressed in brain, kidney, liver, and testis (http://
rafalab.jhsph.edu/barcode/index.php?page=tissuegene). The
original gene expression information in this database was extracted
from publicly available gene expression results of 9,652 samples
using the Mouse Genome 430 2.0 microarray [31]. In this set, a
gene is considered expressed in a specific tissue if it is expressed in
more than 95% of the samples of this tissue. We further extracted
tissue-specific expressed genes by collecting, those that are
expressed in only one of the four tissues. We considered a gene
to be tissue differentially methylated when it has at least one TS-
DMS within the region encompassing 63 Kb from its edges. To
standardize the different lists, all of them were converted to
DAVID identifiers using the Gene ID conversion tool in NIAID’s
DAVID Bioinformatics Resources 6.7 [26,27] website (http://
david.abcc.ncifcrf.gov/). Only genes with DAVID identifiers were
considered in this study. The odds ratio was calculated as the ratio
of the odds of tissue-specific un-methylation occurring in tissue-
specific expressed genes versus the odds of it occurring in non-
tissue-specific expressed genes. Four binary sets of data were
created to calculate the odds ratio (OR) in each tissue according to
the formula: OR=(a/c)/(b/d). Where ‘‘a’’ is the number of genes
tissue differentially methylated that were uniquely expressed in the
same tissue; ‘‘b’’ are genes not associated with TS-DMS but
uniquely expressed in the analyzed tissue; ‘‘c’’ is the number of
genes tissue-differentially-methylated but expressed in more than
one tissue; ‘‘d’’ is the number of genes not associated to TS-DMS
and expressed in more than one tissue. Both ORs and p-values
were calculated by using the logistic regression function in R
package with one degree of freedom.
Overlap between TS-DMS and published tissue-specific
cis-regulatory sequences
We downloaded a list of 32,266 mouse tissue-specific enhancers
in cortex, liver, kidney, and testis identified by H3K4me1 ChIP-
Seq study (http://chromosome.sdsc.edu/mouse/download.html)
[32]. We aligned our identified TS-DMSs and a total of 7 million
surveyed CpGs in the genome to the enhancers based on their
genomic locations. Enhancer was defined as being covered by our
eMSCC method if it has at least one TS-DMS. To quantify the
fold enrichment of TS-DMS in enhancers with respect to the
genome, we calculated the ratio between [number of TS-DMS
within enhancers/total number of TS-DMS] and [total number of
surveyed CpGs within enhancers/total number of surveyed CpGs
in the genome]. We estimated the significance of the enrichments
by simulation, which allowed us to assign p values based on the
distribution of the fold enrichments generated from simulation of
100,000 iterations. For each iteration we randomly generated a set
of genomic regions with the same number of enhancers and the
same size (bp) of each enhancer. In addition, we examined the
overlap of TS-DMS with 15,435 active enhancers, which were
defined by both H3K4me1 and H3K27ac marks.
Functional annotation of CpGs using NIAID’s DAVID
Bioinformatics Resources
We used the tool provided in NIAID’s DAVID Bioinformatics
Resources 6.7 [26,27] to analyze enrichments in five main
Table 2. Association of genes with TS-DMS and tissue specific gene expression in each tissue.
Tissue TS-DMS associated genes TS-expressed genes
1 Overlaps Odds Ratio
2 p-value
3
Brain 1,035 1,080 160 3.18 7.42E-36
Kidney 940 434 52 2.55 7.41E-10
Liver 2,090 878 339 5.5 4.64E-118
Testis 2,700 2,393 438 1.31 1.97E-06
1) Taken from the Gene Expression Barcode 2.0 database (http//:rafalab.jhsph.edu/barcode/).
2) The ratio of the odds of tissue-specific un-methylation occurring in tissue-specific expressed genes.
3) p-values calculated using the logistic regression function in R package with one degree of freedom.
doi:10.1371/journal.pone.0072670.t002
Table 3. Overlap between TS-DMS and tissue-specific enhancers derived from ChIP-Seq H3K4me1 peaks (poised and active
enhancers).
Tissue TS-enhancers TS-DMSs Overlaps
1 # CpG
2 Fold Enrichmen
3 P-value
4
Cortex-Brain
5 8,138 1,149 60; (5.2%) 64,512 5.63 ,1.0 E-5
kidney 5,976 1,115 147 (13.2%) 44,549 20.58 ,1.0 E-5
liver 8,701 2,933 792 (27.0%) 63,053 29.79 ,1.0 E-5
testis 9,451 8,865 3,314 (37.4 3,314 (37.4%) 164,862 15.77 ,1.0 E-5
1) Number of TS-DMS within TS-enhancer regions.
2) Number of surveyed CpGs within TS-enhancer regions.
3) The quotient of two ratios (TS-DMS within TS-enhancer regions/total number of TS-DMSs) and (total number of surveyed CpGs within TS-enhancer regions/total
number of surveyed CpGs in the genome).
4) p-value calculated according to the distribution of the fold enrichments generated from simulation of 100,000 iterations.
5) While these enhancers are derived from cortex the TS-DMS are derived from whole brain.
doi:10.1371/journal.pone.0072670.t003
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function, KEGG pathway, and tissue expression. We used the
Bonferroni-corrected P value of 0.05 as the threshold to identify
significantly enriched categories, which were sorted by -fold
enrichment over the background frequency in the human genome.
We focused on genes associated with CpGs uniquely unmethylated
in one of the four tissues, using gene names derived from the Gene
ID conversion tool within DAVID. A gene was defined as being
associated with a CpG if the CpG was within 3 Kb upstream to
3 Kb downstream of the gene.
Functional enrichment analysis
The functional annotation tables usually display a rank-order
with broader general term at the top, and most specific terms
toward the bottom. Although the upper terms have greater
statistical support (largely enriched, o lower p-values), they are
usually less to almost no informative, but generally are the
reported terms when the main output of the enrichment tool is
based on functional enrichments tables. DAG graph facilitates the
systematic set up of thresholds to select relevant terms based on the
structure of the results. We used Gene Ontology enRIchment
anaLysis and visuaLizAtion tool (GORILLA) [33] which allows to
identify the most informative terms that are significant enriched.
Unsupervised hierarchical clustering analysis
Unsupervised hierarchical cluster analysis was performed with
Cluster 3.0 and displayed using TreeView [34,35].
Results
Identification of Tissue-Specific Differentially Methylated
Sites (TS-DMS)
Brain, kidney, liver and testis were dissected from three C57BL/
6J mice and genomic DNA was isolated from every specimen.
Each sample was treated with four methylation-sensitive restriction
enzymes to compare the extent of digestion at approximately 7
million CpGs. Briefly, twelve CpG-tag libraries were prepared
according to our previously published method [15], and deep
sequenced to generate 37.5 to 51.4 million aligned reads per
sample, Table S1 in Supporting Information S1, Data Set S1.
These reads contain ,27-bp sequences located adjacent to
CCGG, ACGT, GCGC, CCGC and GGCG digested sites.
Digestion frequencies (df ) were calculated by counting the number
of reads aligned to each site in the genome. A site with low df may
indicate either a need for deeper sequencing or that the site is
highly methylated. Three observations support the idea that most
poorly digested sites were associated with high levels of methyl-
ation, rather than with poor coverage or random sampling of
CpG-tags during sequencing: 1) Of the approximately 7 million
CpGs tested across this study, 5,283,360 were represented in the
libraries suggesting an effective coverage; 2) To a large extent, sites
that were resistant to the enzymatic digestion, were arranged in
tandem within the body of genes, repetitive sequences and
intergenic regions. All these places are known to harbor most of
the genomic methylation marks; 3) Digestion frequencies for
poorly identified sites were consistently low in all the tissues and in
all the replicates, which is not expected as a result of random
sampling. Figure 1 illustrates these observations. Each digestion
profile represents the averaged frequencies of three replicates.
Highly digested sites segregate from those resistant to the enzymes.
The majority of sites located in the 59 regions of genes and in CGIs
scored high digestion frequencies, whereas sites in intergenic regions,
repetitive DNA or gene bodies, scored low. Figure 1 shows tissue
specific differentially methylated regions (TS-DMR) spanning the
entire intragenic CGIs in the last exon of several Zinc finger
proteins, Table 1. All these differentially methylated CGIs
distinguish somatic tissues from testis. Indeed, this epigenetic
dichotomy seems to reflect a transcriptional dichotomy, Figure 2.
For instance, the CGI located in the 59 region of the Repin 1 gene
is un-methylated and coincides with DNAse hypersensitivity in all
the somatic tissues, whereas, the intragenic CGI located in the 39
region of the gene is hyper-methylated, and insensitive to DNase I.
Whilst these results uphold the effectiveness of Methyl-Sensitive
Cut Counting (MSCC) to profile methylation [15,36,37], we
harnessed the power of this method to perform a multiple testing
procedure to detect differentially methylated sites (DMS), [38]. By
implementing MSCC in a multiple pairwise comparison design,
we controlled site-specific biases, Figure S1 in Supporting
Information S1. In addition, the variability introduced by random
errors is weighed in the denominator of the equation used to
calculate the t-statistic; this allows us to ascribe the differences in
the digestion frequencies to differences in methylation levels.
Although our experimental design allows for comparisons across
the dynamic range, we contrasted only those sites that are highly
supported by sequencing data. To conduct this selection we first
normalized the libraries to reach similar sequencing depth Figure
S2E in Supporting Information S1. The average df was computed
for every CGI defined by the Takai and Jones algorithm [26]. For
each library, the 21,246 computed scores were organized in a
frequency histogram, Figure S2E in Supporting Information S1.
The figure shows a bimodal distribution that is consistent with the
bimodal pattern of methylation found in CpG islands [39]. As
such the frequency histogram has been used to directly determine
the methylation status of individual CGIs [15], but here we used
Table 4. Overlap between TS-DMSs and active enhancers (H3K27ac and H3K4me1 marks).
Tissue TS-enhancers TS-DMSs Overlaps
1 # CpG
2 Fold Enrichment
3 p-value
4
Cortex-Brain
5 4,128 1,149 43; (3.7%) 33,010 7.89 ,1E - 5
kidney 3,721 1,115 115 (10.3%) 29,187 24.58 ,1E - 5
liver 4,941 2,933 561 (19.1%) 38,697 34.38 ,1E - 5
testis 2,645 8,865 758 (8.6%) 50,783 11.71 ,1.E-5
1) Number of TS-DMSs within enhancers with H3K27ac marks.
2) Number of surveyed CpGs within enhancers with H3K27ac marks.
3) The quotient of two ratios, (number of TS-DMS within H3K27ac enhancers/total number of TS-DMS) and (total number of surveyed CpGs within H3K27enhancers/total
number of surveyed CpGs in the genome).
4) p-value calculated according to the distribution of the fold enrichments generated from simulation of 100,000 iterations.
5) While these enhancers are derived from cortex the TS-DMS are derived from whole brain.
doi:10.1371/journal.pone.0072670.t004
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digestion frequency and rate of methylation at each surveyed CpG. The
sites with a df of 10 or less were considered heavily methylated and
sites not reaching the cut-off in any of the libraries were excluded.
For the identification of DMS multiple pairwise Welch t tests were
performed. The null hypothesis was stated as no difference between
the averages of the triplicates. Based on the differences detected by
the Welch t-test further directional decisions were made to sort the
means according to their values. This allowed the identification of
sites whose rate of digestion was unusually high or low in only one of
the tissues. These sites were called TS-DMS. The test was designed
to control for errors associated with wrong rejections of the null
hypothesis and also for assigning wrong inequality patterns. A
mixed directional false discovery rate (mdFDR) of 10% was chosen
inthisanalysis[25].MousegDNAsampleswerespiked withlambda
gDNA (lDNA) to achieve an equimolar ratio between both
genomes. In this way, for each one of the 1,202 completely un-
methylated sites present in the lambda genome, 12 replicates were
obtained, Data Set S2. Figure S2 A and C in Supporting
Information S1 suggest that df computed for these replicates are
approximately normally distributed with very slight departures in
the tails of the distribution. Comparison of digestion frequencies among
l-gDNA replicates reveals that 10% of the 1,202 l-sites were found
to have significant differences in their digestion frequencies. Although
no differences were expected between the 12 un-methylated lDNA
replicates, our results show that these empirical values for false
discovery rate were very close to the theoretical value of 10%
selected for this study.
Applied to CpGs from the mouse genome the comparative
differences reveals 150,428 sites where the methylation varies to
the same extent among the analyzed four tissues. Furthermore,
retaining only the sites whose digestion frequencies differed by a
minimum of 10 resulted in a final count of 138,052 DMS (Data
Set S3). Only 24,803 of these DMS were TS-DMS, i.e. sites that
were hypo or hyper-methylated in only one tissue, Figure 3.
Notably, 23,270 (94%) of these TS-DMS are un-methylated CpGs
in one of the four tissues, of which 57% were in the testis.
Distribution of TS-DMS in relation to Genes and CpG
Islands
An overwhelming number of genome-wide methylation studies
focused on CGIs and promoter regions have proposed them as hot
spots for epigenetic control of gene expression through CpG
methylation [40]. To investigate if our results are consistent with
this concept, we compared the distribution of sites having a
comparable methylation level among the four tissues with the
distribution of TS-DMS. Almost all the sites identified as DMS or
TS-DMS were found in introns or intergenic regions which are
remote from promoters, Figure 4A. Recently, it has been proposed
that intergenic and intragenic CGIs function as alternative
promoters which can be repressed in a tissue specific manner
through methylation of their CpGs [11,12,14]. However we found
that only 5 to 25% of TS-DMS were parts of CpG islands. The
fraction of TS-DMS in CGIs increased proportionally to the
number of island in each set, Figure 4-B.
Most recently, CGI shores, not CGI, have been proposed to be
the targets of tissue-specific epigenetic regulation [41,42]. We
found that the fraction of TS-DMS mapping to CGI shores (2000
base pairs from the edge of a CGI) follows the same trend and
proportions than those mapping to CGIs, Figure 4B. The different
CGI sets used in this study represent efforts to improve predictions
of functionality on GC-rich genomic sequences, mainly promoter
activity and un-methylated status. Notably the Gardiner- Garden
and Frommer’s set (GGF-CGI), which is the oldest, biggest and
considered the less rigorous in term of functional prediction, is the
one that collects the biggest number of TS-DMS. Approximately
60% of the tissue specific un-methylated CpGs are equally
distributed between GGF-CGI and their shores. Conversely, the
GGF-CGI-derived more stringent sets, such as those produced
applying the Takai and Jones criteria [26] or with an epigenome
prediction pipeline [28], are the ones containing the smallest
fractions of TS-DMS in their CGIs or shores, Figure 4b. Thus the
main characteristic in a set correlating with the proportion of TS-
DMS is their number of predicted CpG rich loci, suggesting that
the effort done to improve the prediction of epigenetically
regulatory sequences in a genome failed to capture the DNA
features that guide tissue-specific epigenetic mechanisms.
Association between TS-DMS and tissue-specific
expressed genes
The Gene Expression Barcode browser contains a list of genes
whose levels of expression, in 89 murine tissues, were represented
as binary calls (expressed or not-expressed) [31]. These lists were
made from 9,652 publicly available gene expression results
Figure 5. DAG graphical representation of the functional profiles extracted from genes associated to liver specific un-methylated
sites. 2500 genes directly linked to liver specific TS-DMS were input in the Gorilla tool. Enriched GO terms are depicted using a direct acyclic graph
with color code reflecting the statistical support of their enrichment. Most significant branches whit not redundant nodes are shown separately for
enhanced detail.
doi:10.1371/journal.pone.0072670.g005
Table 5. Enrichment of tissue-specific gene expression annotations performed with the DAVID Bioinformatics Resources.
TS-DMS
1 TS-DMS in genes
2 Genes with TS-DMS TS-genes
3 % p-value
4
Brain 2382 1402 1098 575 52 5.6 E-36
Kidney 2177 1250 999 170 17 7.6 E-8
Liver 5626 3326 2218 702 32 1.1 E-79
Testes 13058 5848 3042 598 20 3.8 E-5
1) Number of CpGs that were identified as uniquely un-methylated.
2) Number of TS-DMS located in the region spanned from 63 kb of the gene edges.
3) Genes annotated as tissue-specific expressed.
4) Adjusted p-values (Bonferroni correction for family-wise error rate).
doi:10.1371/journal.pone.0072670.t005
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GO Term
1 Description P-value FDR q-value Enrichment B
2 b
3
Liver
GO:0042632 cholesterol homeostasis 1.79E-13 4.42E-11 5.31 48 25
GO:0008203 cholesterol metabolic process 5.52E-13 1.14E-10 3.94 88 34
GO:1901606 alpha-amino acid catabolic process 2.17E-10 3.05E-08 4.11 62 25
GO:0007169 transmembrane receptor protein tyrosine kinase signaling
pathway
3.30E-10 4.56E-08 2.39 243 57
GO:0007584 response to nutrient 3.64E-08 3.56E-06 4.27 43 18
GO:0070328 triglyceride homeostasis 4.60E-08 4.35E-06 6.11 20 12
GO:0006633 fatty acid biosynthetic process 4.94E-08 4.60E-06 2.91 105 30
GO:0046889 positive regulation of lipid biosynthetic process 1.08E-07 9.55E-06 3.71 55 20
GO:0090207 regulation of triglyceride metabolic process 1.26E-07 1.10E-05 5.3 25 13
GO:0033344 cholesterol efflux 1.95E-07 1.61E-05 5.56 22 12
Brain
GO:0007399 nervous system development 1.30E-08 2.26E-06 2.69 307 40
GO:0007411 axon guidance 1.71E-08 2.76E-06 3.66 141 25
GO:0007409 axonogenesis 1.98E-08 3.11E-06 3.75 132 24
GO:0007169 transmembrane receptor protein tyrosine kinase signaling
pathway
8.11E-08 1.07E-05 2.81 242 33
GO:0070588 calcium ion transmembrane transport 7.17E-07 7.43E-05 3.87 96 18
GO:0071902 positive regulation of protein serine/threonine kinase activity 1.20E-06 1.20E-04 2.81 198 27
GO:0007163 establishment or maintenance of cell polarity 2.00E-06 1.89E-04 3.98 83 16
GO:0006813 potassium ion transport 2.18E-06 2.04E-04 3.21 135 21
GO:0007626 locomotory behavior 2.94E-06 2.56E-04 2.97 160 23
GO:0050772 positive regulation of axonogenesis 3.47E-06 2.95E-04 4.95 50 12
Testes
GO:0071805 potassium ion transmembrane transport 1.63E-08 5.94E-06 2.82 86 32
GO:0006816 calcium ion transport 3.98E-07 1.05E-04 2.08 175 48
GO:0007156 homophilic cell adhesion 5.06E-07 1.30E-04 2.78 71 26
GO:0007411 axon guidance 5.15E-07 1.30E-04 2.21 141 41
GO:0007126 meiosis 1.89E-06 3.95E-04 2.47 89 29
GO:0070192 chromosome organization involved in meiosis 2.27E-06 4.67E-04 3.67 31 15
GO:2000310 regulation of N-methyl-D-aspartate selective glutamate receptor
activity
3.17E-06 6.09E-04 6.07 10 8
GO:0060079 regulation of excitatory postsynaptic membrane potential 4.53E-06 7.89E-04 3.22 40 17
GO:0032673 regulation of interleukin-4 production 8.87E-06 1.34E-03 3.96 23 12
GO:0007283 spermatogenesis 7.38E-05 7.66E-03 2.05 267 58
Kidney
GO:0030029 actin filament-based process 9.49E-05 8.38E-03 2.35 232 24
GO:0006820 anion transport 6.78E-05 6.33E-03 2.16 316 30
GO:0022610 biological adhesion 3.49E-07 9.86E-05 2.03 639 57
GO:0007167 enzyme linked receptor protein signaling pathway 6.11E-05 5.81E-03 2.06 376 34
GO:0046847 filopodium assembly 4.26E-07 1.18E-04 8.53 24 9
GO:0016570 histone modification 5.33E-05 5.33E-03 2.39 238 25
GO:0042490 mechanoreceptor differentiation 2.55E-05 2.98E-03 6.27 29 8
GO:0030512 negative regulation of transforming growth factor beta receptor
signaling pathway
1.05E-05 1.47E-03 5.41 42 10
GO:0009887 organ morphogenesis 5.03E-06 7.89E-04 2.2 393 38
GO:0035335 peptidyl-tyrosine dephosphorylation 5.82E-05 5.68E-03 4.99 41 9
GO:0043065 positive regulation of apoptotic process 3.30E-05 3.80E-03 2 443 39
1) GO terms at the terminal nodes of the DAG, p-values,0.0001 and enrichments bigger than 2 are displayed in the table.
2) ‘‘B’’ is the total number of genes in the background dataset annotated with GO term in row.
3) ‘‘b’’ is the number of genes in the ‘experimental set’ that are associated with the GO term in row.
doi:10.1371/journal.pone.0072670.t006
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above threshold in more than 95% of samples of a specific tissue
are considered expressed in that tissue. We considered a gene to be
expressed in a tissue-specific manner when it is expressed in only
one of the four organs included in our study. In addition we
created a list including all the genes with at least one TS-DMS in
the region extending from -3 Kb to +3 Kb of the edges of the
gene. We found that genes associated with TS-DMS are more
likely to be expressed in a tissue specific manner. The strength of
this association varies across the different tissues, Table 2.
TS-DMS are more frequently found at CpGs inside tissue
specific cis-regulatory sequences
A map of cis-regulatory elements for the mouse genome has
recently been published [32]. The map includes 53,834 putative
promoters and 234,764 potential enhancers, many of which are
tissue specific. These enhancers were defined according to the
presence of ChIP-Seq peaks for histone H3 lysine 4 mono-
methylation marks (H3K4me1) outside promoters. We obtained
the coordinates for 24,128 tissue-specific enhancers that are
divided between liver, kidney and testis (http://chromosome.sdsc.
edu/mouse/download.html). We compared the relative number of
TS-DMS and surveyed CpG sites inside and outside of these
enhancer-DNA sequences. We found that the percentage of TS-
DMS within enhancers is up to 30 times higher than outside
enhancers Table 3 (p-value,10
25, simulation of 100,000
iterations), with enrichment varying across tissues. Next we
examined the overlap of TS-DMS with active enhancers, as
defined by acetylation marks (H3K27ac), [32] (Table 4). A
comparison of the results (Table 3 with Table 4) shows that most of
the TS-DMS derived from somatic tissues are localized in active
enhancers, while the opposite is true for the case of the TS-DMS
derived from the testis. For example, of the 792 TS-DMS marking
enhancers in liver, 561 (70%) are in active enhancers.
Genes associated with TS-DMS are enriched in functional
annotations specific to the corresponding tissue
We created two lists representing different levels of association
between the TS-DMS and their corresponding genes, Data Set S4.
If a TS-DMS is outside the region occupied by the gene
63,000 bp it was assigned to the nearest TSS (weak association).
If a TS-DMS is inside the region occupied by the gene 63,000 bp
it was directly assigned to that gene (strong association). Gene
annotation enrichment analyses using these gene lists were mainly
based on the Gene Ontology data base (GO) [43]. To obtain the
functional profiles we used DAVID Bioinformatics Resources
[44,45] and Gene Ontology enRIchment anaLysis and visuaLi-
zAtion tool (GORILLA) [33]. Genes associated with TS-DMS
were significantly enriched in tissue-specific expression annotation
in each of the four tissues, (Table 5). Table 6 tabulates the
functional enrichment results for biological processes in the
context of a directed acyclic graph (DAG) structure created using
the GOrilla tool, e.g. Figure 5. The table includes all the terms at
terminal nodes of the DAG describing the most specific and
informative biological processes that showed significant enrich-
ment. Terms described in these sets matched distinct attributes of
the physiology and biochemistry of each particular tissue, Figures 5
and Figures S3and S4 in Supporting Information S1, also Table 6.
Interestingly, genes physically linked to TS-DMS are mostly
associated with typical activities of the respective adult organ,
whilst many genes with TS-DMS distal to their promoters are
associated with embryonic development, Table 6 and Figure S4 in
Supporting Information S1. Finally, we scored and ranked the
genes according to the number of TS-DMS associated with them,
and used the GOrilla tool to discover GO terms that are
significantly enriched at the top of a ranked gene list. In the case
of liver, we found very high enrichments for genes involved in lipid
metabolism and homeostasis, particularly for processes including
synthesis, transport and cellular response to cholesterol, Table 7.
Table 7. Significantly enriched GO terms at the top of a ranked gene list
1.
GO Term Description P-value FDR q-value Enrichment B
2 b
3
GO:0071396 cellular response to lipid 5.33E-07 3.36E-03 18.49 37 7
GO:0042592 homeostatic process 3.14E-06 9.88E-03 6.52 165 11
GO:0048878 chemical homeostasis 4.75E-06 9.97E-03 7.29 134 10
GO:0032844 regulation of homeostatic process 6.01E-06 9.46E-03 45.26 38 4
GO:0033993 response to lipid 6.62E-06 8.34E-03 10.29 76 8
GO:0034383 low-density lipoprotein particle clearance 8.32E-06 8.73E-03 27.74 5 4
GO:0055088 lipid homeostasis 1.40E-05 1.26E-02 15.85 37 6
GO:0009755 hormone-mediated signaling pathway 2.15E-05 1.70E-02 4.02 23 13
GO:0034381 plasma lipoprotein particle clearance 2.45E-05 1.72E-02 17.34 10 5
GO:0030301 cholesterol transport 2.55E-05 1.61E-02 13 16 6
GO:0015918 sterol transport 2.55E-05 1.46E-02 13 16 6
GO:0055092 sterol homeostasis 2.70E-05 1.42E-02 13.95 25 6
GO:0042632 cholesterol homeostasis 2.70E-05 1.31E-02 13.95 25 6
GO:2000021 regulation of ion homeostasis 4.76E-05 2.14E-02 71.67 18 3
GO:0043691 reverse cholesterol transport 4.97E-05 2.09E-02 61.43 7 3
GO:0065008 regulation of biological quality 7.28E-05 2.87E-02 4.04 290 12
1) 4,265 genes were ranked according to their contain in TS-DMS. The Gorilla web-based application was used to identify enriched GO terms at the top of the ranked list
of genes.
2) ‘‘B’’ is the total number of genes in the background dataset annotated with GO term in row.
3) ‘‘b’’ is the number of genes in the ‘experimental set’ that are associated with the GO term in row.
doi:10.1371/journal.pone.0072670.t007
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replicates are assessed with unsupervised cluster analysis. The
length of the branches in the hierarchical dendrogram measures the
person correlation distances between digestion frequencies scored by
CpGs identified as spot of tissue differential methylation. Shown are
heat maps of the log2-transformed digestion frequencies (red: more than
50 reads per CpG, i.e., un-methylated; black: 0 reads per CpG, i.e.,
methylated). Rows represent the first 40 CpGs in the final cluster; each
column represents one of the 12 tissue samples. A) 138,052 T-DMS. B)
23,270 TS-DMS (only the tissue specific un-methylated sites were
clustered). C) MSCC data produced from livers of 16 outbred mice were
combined with MSCC data of the 12 tissue samples. D) MSCC data
produced from a liver of a C57BL/6J 12.5 d embryo was combined with
MSCC data of the 12 tissue samples.
doi:10.1371/journal.pone.0072670.g006
Figure 7. Epigenetic distances between livers of mice exposed
to in utero or postnatal food restriction. The length of the
branches in the hierarchical dendrogram measures the person
correlation distances between digestion frequencies scored by CpGs
identified as spot of epialleles. Shown are heat maps of the log2-
transformed digestion frequencies (red: more than 50 reads per CpG, i.e.,
un-methylated; black: 0 reads per CpG, i.e., methylated). Rows represent
the first 40 CpGs in the final clusters; each column represents one of the
16 tissue samples from this study. Only the field with the first 40 TS-
DMS in the cluster are depicted A) Design of mouse feeding experiment
(Joslin feeding protocol; adapted from [23]) B) MSCC data produced
from livers of the CC, CU and UU groups. 16 outbred mice were
combined with MSCC data of the 12 tissue samples. D) MSCC data
produced from a liver of a C57BL/6J 12.5 d embryo was combined with
MSCC data of the 12 tissue samples.
doi:10.1371/journal.pone.0072670.g007
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adult mouse liver
We performed an unsupervised hierarchical clustering analysis
to visualize the TS-DMS structure between and within tissue
samples as a hierarchical dendrogram where the branch lengths
represent the degree of epigenetic similarity between samples.
Samples from the same tissues were grouped together regardless of
whether DMS or TS-DMS dataset was used (Figure 6 A and B).
These results suggest that the DMS identified among 6,955,111-
surveyed CpGs have the potential to function as tissue-specific
methylation fingerprints.
We next tested if the liver specific DMS can be used as a unique
epigenetic signature of the adult mouse liver. We combined the
DMS found in the four-tissue dataset with similar data obtained
from livers of 16 outbred mice and also the liver from a E11.5
C57BL/6J embryo. Despite the differences in the genetic
background among these samples, the livers from all 19 mice
co-clustered separately from brain, kidney, and testis, Figure 6C. A
sample derived from embryonic liver (E11.5) was most similar to
the adult liver samples than those from other organs, but still
clustered separately from adult-stage liver, Figure 6D.
A set of DMS derived from mice livers can trace
nutritional history
Given the critical role of the liver in controlling whole-body
metabolism, and the high frequency of TS-DMS in genes that
control key aspects of the hepatic lipid homeostasis Figure S3 in
Supporting Information S1, we analyzed the impact of prenatal
and postnatal nutrient availability on liver methylation patterns.
Differentially methylated sites (DMS) were isolated from mice
whose mothers had been subjected to four different feeding
protocols [23]: CC, prenatal and postnatal control diet; CU,
prenatal control diet and postnatal food restriction; UU, prenatal
and postnatal food restriction; UC, prenatal food restriction and
postnatal control diet (for details see [23]). Comparison of CC, CU
and UU liver samples led to the identification of 5,574 DMS
(mdFDR 15%), Data Set S5. Practically all these DMS were hypo-
methylated in mice that were exposed to a control diet during the
whole experiment (CC) but hyper-methylated in those mice
exposed to any of the diets including food restriction (UC, CU or
UU). Out of these 5,574 DMS induced for food restriction, 533
were previously identified as differentially methylated sites in the
comparisons among the four tissues (vide supra). Remarkably genes
associated with these 533 DMS were highly enriched (between 4 to
15 times) in annotations related to SMAD protein signal
transduction, steroid and fatty acid metabolic process.
We examined to what extent these DMS can function as
epigenetic signatures of each nutritional exposure. Unsupervised
clustering of MSCC data obtained from 4 CC, 5 CU, and 5 UU
samples regrouped experiments according to the treatment,
Figure 7B. When data from a different treatment was included
(UC) the samples clustered outside the previous defined groups,
Figure 7B. We inferred that these DMS constitute epialleles that
traced the nutritional history of mice during the in utero and/or
immediate postnatal stages.
Discussion
Based on our expanded methyl-sensitive cut counting (eMSCC)
method [15], we screened for differential methylation in gDNA
samples derived from liver, kidney, brain and testis. We detected
138,052 differentially methylated sites, of which 24,803 were
uniquely methylated or un-methylated in one but not in the other
tissues (Figure 3). Strikingly, 23,270 (93%) of these TS-DMS were
hypomethylated, suggesting that un-methylation rather that
methylation is the epigenetic state highlighting developmentally
active loci.
In agreement with previous results obtained by Restriction
Landmark Genomic Scanning (RLGS) or Methylated DNA
Immunoprecipitation (MeDIP), we found that most TS-DMS
represent differences between the testis and somatic tissues
[17,18,46–48]. Interestingly and more often in testis, many TS-
DMS co-localize in CpG islands or CpG clusters to form testis-
specific un-methylated regions within gene bodies or gene deserts.
The transcriptional landscape around these loci seems inconsistent
with the notion that they may represent alternative promoters
(Figure 1) [11,12,14]. A particularly interesting result is that tissue-
specific differential methylation at intragenic CpG clusters
correlates with tissue-specific differential expression of zinc finger
protein genes (Zfp), We found 39 Zfp genes with a differentially
methyled region in the 39 terminal exon that is invariably
methylated in somatic tissues and hypomethylated in testis,
(Table 1). Remarkably, most of them follow a similar inverse
relationship between the level of methylation at the 39 terminal
exon and gene transcriptional activity, Figure 2. It is intriguing
why their TSSs remain largely un-methylated in all tissues but
their intragenic CGIs seem to be preferential sites for de novo
methylation in somatic tissues during development. The lack of
differential methylation at the promoter CGIs suggests a limited
role for these loci in the epigenetic transcriptional regulation,
however aberrant methylation marks in the promoters of a Zfp
correlates with cervical cancer [49]. Probably, the 39 exons start
the developmental program as un-methylated regions, acquiring
methyl-marks as the embryo develops into adult. For instance,
spatio-temporal and cell-specific methylation of these exonic-
CpGs could avoid the binding of a gene repressor. Most of Zfp
genes described in Table 1 belong to the C2H2 Zf family, which
are enriched in KAP 1 repressor target sites. Interestingly ChiP-
chip experiment detected most of the KAP1 binding sites towards
the 39 transcribed regions of these Zf-genes, [50]. Alternatively, the
exonic-DNA methylation could turn the chromatin in to a Pol II
elongation-permissive state. For example it has been recently
shown that H3K79, H4K20, H2BK5 and H3K36m3 mark
nucleosomes wrapping exonic-DNA. The tri-methylation of
H3K36 is the most prominent mark and correlates positively with
increased gene expression levels and stimulated transcriptional
elongation [51–53]. In agreement with the positions of TS-DMS
we found in the Zfp genes, H3K36me3 is primarily found in
downstream exons, [53]. The co-occurrence of H3K36me3 and
DNA hypermethylation has been recently shown in the bodies of
zinc finger genes along chromosome 9, [54]. When all genes
covered by this study were considered, these authors found that
the co-occurrence between H3K36me3 and hypermethylation was
more frequently observed at last exons or at highly expressed
genes. Overall the data suggest that differential methylation of Zfp
genes at 39 exons constitutes a developmental epigenetic signature.
Some of these same genes have been already identified as playing
key roles in cell fate specification, [55]. It will be interesting to
follow the dynamics of gene expression and methylation at these
loci during embryonic development.
We observed intriguing differences in the methylation pattern of
DNA derived from testis. Firstly, the largest numbers of TS-DMS
were observed in testes. However, testis showed the weakest
association of TS-DMS with active enhancers or tissue-specific
gene expression (Tables 2, 4, and 5). Secondly, testis TS-DMS
were localized at loci encoding genes involved in the embryonic
development of multiple organs and anatomical structures, Figure
S4 in Supporting Information S1 and Table 6. Whilst we
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data suggest that part of the epigenetic information involved in
development would be pre-coded in the sperm genome.
The presence of differentially methylated CGIs is rarer in
somatic tissues, by contrast most TS-DMS are located far from
promoters, in loci with scarce CpGs and in many overlapping
regions reported as tissue-specific enhancers. Indeed we found that
local DNA hypomethylation highlighted active enhancers
(H3K4me1 and H3K27me3) in a tissue-specific manner. Indeed,
it has recently been shown that transcription factors (TF) can
actively induce open chromatin spots and local de-methylation of
low CpG density sequences, which ultimately constitute a footprint
for DNA regulatory elements [16,56]. Despite the scarcity of
methylable sites in these elements, the methylation of critical CpGs
was sufficient to prevent the TF-DNA interaction, [56].
Not only did we find active enhancers highly enriched in TS-
DMS, but we also found that genes spotted with TS-DMS are
expressed in a tissue-specific manner, (Tables 2 and 5) with their
functional profiles matching specific functions of the correspond-
ing tissues. Considering all our data we suggest that most of the
sequences having TS-DMS must be cis-acting elements for tissue-
specific trans-acting factors.
To assess the extent to which the TS-DMS could demarcate
tissue-specific physiological aspects, we performed annotation
enrichment analysis in the set of genes associated with these
epigenetic marks. We found that the position of the TS-DMS in
relation to genes defines two types of functional profiles. When
TS-DMS are found in intergenic regions and distant from gene
boundaries, there is a notable enrichment in processes related to
embryonic development Figure S4 in Supporting Information S1.
In the instance where TS-DMS are within or very near to the
borders of the gene, most of the biological processes describe
physiological and organ-specific functions, (Table 6). A remarkable
observation is that genes involved in specific liver functions such
as, hepatic cholesterol homeostasis, response to nutrients, response
to peptide hormones, plasma clearance of lipoproteins and
metabolic control of xenobiotic, are distinguished in the liver
genome by the presence of TS-DMS, (Figure 5 and Figure S3 in
Supporting Information S1. Indeed, by ranking genes according to
the number of TS-DMS and querying for enriched GO terms at
the top of a ranked list, we found a selective increase in functional
specificity towards lipid homeostasis, especially hepatic cholesterol
management, Table 7.
We speculate that the high incidence of TS-DMS demarcating
key genetic aspects of hepatic physiology could account for many
of the findings that report associations between epigenetic
alterations and metabolic disorders. Multiple studies have dem-
onstrated that the nutritional state during sensitive developmental
periods, including the intrauterine life and lactation periods, can
‘‘program’’ developmental trajectories to improve the ability of the
fetus to survive in similar postnatal environments. Unfortunately,
these adaptations may also modulate risk for metabolic disease in
adult life. An attractive hypothesis is that these effects of nutritional
exposures are mediated by altered epigenetic regulation of
transcription. Whether methylation is the primary triggering
event, or mediated by histone modification or effects of noncoding
RNAs, remains unclear. However, our data suggest that differen-
tial methylation may mark key developmental loci, which are
susceptible to nutritional or other environmental insults.
We identified thousands of sites whose differentially methylated
status generated epialleles in the offspring of mothers subjected to
different feeding protocols (Figure 7, Data Set S5). We used
correlation distances to look for comparable variations in the
magnitude of digestion frequencies in the sites detected as
differentially methylated. Unsupervised cluster analysis shows that
this set of epi-alleles characterize the nutritional history of each
mouse.
In summary, in the present work we extended our previous
observation that outside of CGIs and promoters there are a large
number of regions with hypomethylated CpG, at low density.
These regions not only outnumber the CGI but also are the loci
with the greater enrichment in regulatory sequences, [15,16]. Here
we show that CpGs that are part of TS-DMS are also typically
found far from promoters and outside of CGIs. TS-DMS are
enriched in sequences recognized as tissue-specific enhancers and
associated with tissue-specific expressed genes. Genes associated
with these sites fulfill roles in the development of the corresponding
tissue but also in their specific physiological functions. The
identification of loci with aberrant DNA methylation marks has
been largely extended during the last 5 years. Our results agree
with the idea that epi-mutation rather than mutations better
explain the developmental origin of diseases [57]. Most of the
work on disease-related DNA methylation has focused on
hypermethylation of CGI in cancer. Thus, the relevance of
aberrant methylation marks outside CGI in human disease has not
been well studied. Here we show that during development
methylation of CpGs outside promoter or CGI seemed to be far
more dynamic than commonly appreciated. We propose that the
catalog of TS-DMS presented in this work, particularly those
linked to the hepatic function could constitute a comprehensive
epi-panel for detection and diagnosis of metabolic diseases.
Supporting Information
Supporting Information S1 This file contains Table S1 and
Figure S1–Figure S4. Table S1, which is a summary of the results
of the short-reads-alignments to the NCBI37/mm9 assembly
mouse reference genome; Figure S1, showing the influence of
random sampling and systematic bias are canceling out during the
pairwise site-by-site comparisons; Figure S2, Validating of the
assumption of normality for the distribution of digestion
frequencies (methyl sensitive cut counts) in CpGs from both
lambda and mouse replicates; Figure S3, detailing the biological
regulation branch showed in Figure 5 and Figure S4, showing the
functional enrichment analysis results for genes proximal to TS-
DMS located at intergenic regions. A description of the column
headers in Data Sets S1 to S5 is provided in tables at the end of the
document.
(PDF)
Data Set S1 Methyl Sensitive Cut Counting Results for CpG
sites surveyed in the mouse genome
(ZIP)
Data Set S2 Methyl Sensitive Cut Counting Results for CpG
sites surveyed in the lambda phage genome
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Data Set S3 138,052 differentially methylated sites (DMS), their
genomic coordinates and their closest
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Data Set S4 List of genes used for Gene Ontology enrichment
analysis
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methylated CpGs
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